Brand Name(s): | IMPORTANT WARNING: | WHY is this medicine prescribed? | HOW should this medicine be used? | Are there OTHER USES for this medicine? | What SPECIAL DIETARY instructions should I follow? | What should I do IF I FORGET to take a dose? | What SIDE EFFECTS can this medicine cause? | What should I know about STORAGE and DISPOSAL of this medication? | What should I do in case of OVERDOSE? | What OTHER INFORMATION should I know? | ahfsCopyRight

Brand Name(s):

  • Esidrix®¶
  • Hydrodiuril®¶
  • Microzide®
  • Oretic®
  • Zide®¶
  • Amturnide®(as a combination product containing Aliskiren, Amlodipine, Hydrochlorothiazide)
  • Apresazide®(as a combination product containing Hydralazine, Hydrochlorothiazide)
  • Accuretic®(as a combination product containing Quinapril, Hydrochlorothiazide)
  • Benicar®HCT (as a combination product containing Olmesartan, Hydrochlorothiazide)
  • Diovan®HCT (as a combination product containing Valsartan, Hydrochlorothiazide)
  • Dutoprol®(as a combination product containing Metoprolol, Hydrochlorothiazide)
  • Exforge®HCT (as a combination product containing Amlodipine, Hydrochlorothiazide, Valsartan)
  • Hydrap-ES®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Hydro-Reserp®(as a combination product containing Hydrochlorothiazide, Reserpine)
  • Hydropres®(as a combination product containing Hydrochlorothiazide, Reserpine)
  • Hydroserp®(as a combination product containing Hydrochlorothiazide, Reserpine)
  • Hydroserpine®(as a combination product containing Hydrochlorothiazide, Reserpine)
  • Hydra-Zide®(as a combination product containing Hydralazine, Hydrochlorothiazide)
  • Inderide®(as a combination product containing Hydrochlorothiazide, Propranolol)
  • Inderide®LA (as a combination product containing Hydrochlorothiazide, Propranolol)
  • Lopressor®HCT (as a combination product containing Metoprolol, Hydrochlorothiazide)
  • Mallopress®(as a combination product containing Hydrochlorothiazide, Reserpine)
  • Marpres®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Monopril®HCT (as a combination product containing Fosinopril, Hydrochlorothiazide)
  • Normozide®(as a combination product containing Labetalol, Hydrochlorothiazide)¶
  • Quinaretic®(as a combination product containing Quinapril, Hydrochlorothiazide)
  • Ser-Ap-Es®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Serathide®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Serpazide®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Serpex®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Tekturna®HCT (as a combination product containing Aliskiren, Hydrochlorothiazide)
  • Teveten®HCT (as a combination product containing Eprosartan, Hydrochlorothiazide)
  • Timolide®(as a combination product containing Timolol, Hydrochlorothiazide)
  • Trandate HCT®(as a combination product containing Labetalol, Hydrochlorothiazide)¶
  • Tri-Hydroserpine®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Tribenzor®(as a combination product containing Amlodipine, Hydrochlorothiazide, Olmesartan)
  • Uni Serp®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Unipres®(as a combination product containing Hydralazine, Hydrochlorothiazide, Reserpine)
  • Uniretic®(as a combination product containing Moexipril, Hydrochlorothiazide)
  • Ziac®(as a combination product containing Bisoprolol, Hydrochlorothiazide)

IMPORTANT WARNING:

This MedWatch affects the following medications:

  • Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide)
  • Tekturna (aliskiren hemifumarate)
  • Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide)
  • Tekamlo (aliskiren hemifumarate and amlodipine besylate)
  • Valturna (aliskiren hemifumarate and valsartan). Valturna will no longer be marketed after July 2012.

[Posted 04/20/2012]ISSUE:FDA notified healthcare professionals of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or kidney (renal) impairment. These drug combinations should not be used (are contraindicated) in patients with diabetes. In addition, avoid use of aliskiren with ARBs or ACEIs in patients with moderate to severe renal impairment (i.e., where glomerular filtration rate [GFR] < 60 mL/min). The labels for the aliskiren drugs are being updated based on preliminary data from a clinical trial, ''Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE).''

BACKGROUND:Aliskiren is a renin inhibitor used to treat high blood pressure (hypertension) by lowering blood pressure.

RECOMMENDATION:Concomitant use of aliskiren with ARBs or ACEIs in patients with diabetes is contraindicated because of the risk of renal impairment, hypotension, and hyperkalemia. Avoid use of aliskiren with ARBs or ACEIs in patients with renal impairment where GFR < 60 mL/min. Patients should not stop taking aliskiren without talking to your healthcare professional. Stopping aliskiren suddenly can cause problems if your high blood pressure (hypertension) is not treated.

See the Drug Safety Communication for the Data Summary at: Web Sitefor a list of ACEI and ARB products, and additional recommendations for healthcare professionals and patients. For more information visit the FDA website at: Web Siteand Web Site.